RE:INSIDER...Recall for the newbies...
First who is Dietrich Stephan????...
1) Dietrich Stephan is a genetisist by profession(studies genes,RNA,DNA...) with the scientific background to fully understand the potential of Genenews tests(he knows more about genes than Jame Tripp himself).
2) Dietrich Stephan is the CEO of a very impressive and influantial company LifeX who is in a partnership with Genenews.
3) Dietrich Stephan strongly believe that Genenews tests are the'' Holy Grail of cancer tests ''.
wildbird1 wrote: If you take the time to read the ''Investor Presentation'' and the ''CC (conference call transcript)'', you will notice that Genenews seem to be very serious about the 2019, $30 Million revenues estimate.
In order to achieve this $30 Million estimate, it is primordial that genenews sign on, at least one big Healthcare System.
According to ''US News & World Report'', UPMC ( University Pittsburgh Medical Center)
is ranked as one of the top commercial Health Plan, as well as one of the largest Healthcare System in the US.
Question? What are the chance that Genenews will be able to sign on UPMC big Healthcare System.
Answer: Quite good.
Why? Because we have an insider working fo Genenews...Dietrich Stephan LifeX CEO, is also chairman of the department of human genetics at UPMC.
PressRelease Nov 15, 2018...
Genenews said (Quote) Our partnership with LifeX (Dietrich Stephan) to expand the adoption and use of Genenews ''Liquid Biopsy'', into large multi-entity Healthcare System is progressing well (End of QUOTE).
With an insider working for Genenews, and an estimate of $30 Million revenues in 2019, I will let you guess how close Genenews is to sign on a very large Healthcare System (UPMC).